🌎 Ares Management Upgraded, Vaxcyte Initiated, Rhythm Pharmaceuticals Initiated…

Ratings changes for Rigetti Computing, Micron Technology, Palantir Technologies, Applied Digital, MannKind, Humacyte, Innoviz Technologies and more…Upgrade to MarketBeat All Access to get early delivery, personalized stock alerts, portfolio monitoring tools, and more. Start Your Free Trial.

Unsubscribe.

VIEW MY PORTFOLIO

DECEMBER 20TH, 2024

Why Trump’s Win Can’t Stop the Coming Crisis – Protect Yourself Now (ad)

For the first time in years, you can feel a crackling energy…

And a reason to be hopeful for the future again.

It’s like we woke up in a different America.

And maybe we can finally move on from under the dark cloud that seemed to hang over this country for the past years.

WATCH MY EMERGENCY BRIEFING HERE >>>

Today’s Top Stories

2 Underrated Quantum Computing Companies Starting to Rally

BY NATHAN REIFF | DECEMBER 20, 2024 09:00 AM

Missed Nvidia? Buy Elon Musk’s “Silent Partner” (Ad)

BY BROWNSTONE RESEARCH

Trump was poised to inherit a strong economy. Then things got rocky and he added to the uncertainty

BY THE ASSOCIATED PRESS | DECEMBER 20, 2024 06:00 AM

Why Wall Street Sees Major Upside for PayPal Stock

BY GABRIEL OSORIO-MAZILLI | DECEMBER 20, 2024 08:00 AM

BITCOIN (Ad)

BY AWESOMELY, LLC

Russian central bank holds rates steady even as war against Ukraine fuels inflation

BY THE ASSOCIATED PRESS | DECEMBER 20, 2024 05:14 AM

Cintas Shares Slide: A Prime Opportunity to Buy the Dip

BY THOMAS HUGHES | DECEMBER 20, 2024 08:00 AM

Quick Links

MarketBeat All Access

25X predicted for “Amazon Coin” – starting December 16th? (ad)

This tiny 3-cent crypto just partnered with one of the biggest companies in the world… Amazon.

And one team of crypto experts has identified it as the most promising crypto of 2024.

You can see all of the details surrounding the #1 Crypto of 2024

>3-CENT AMAZON COIN<

Your Watchlist

MANAGE YOUR WATCHLIST AND MONITOR YOUR PORTFOLIO

Apple Inc. (AAPL)

(12/20) Jabil’s Winning Streak Begins: Market Bottom Set, Future in Focus (AAPL) (marketbeat.com)
(12/20) Apple Inc. (NASDAQ:AAPL) Shares Sold by Maryland Capital Advisors Inc. (marketbeat.com)
(12/19) OpenAI Expands ChatGPT Integration with Apple Desktop Apps (gurufocus.com)
(12/19) OpenAI Launches ChatGPT Support for More Apple Desktop Apps (pymnts.com)
(12/19) Apple (AAPL) Rises As Market Takes a Dip: Key Facts (zacks.com)

Amazon.com, Inc. (AMZN)

(12/20) Top 5 Retail Stocks Poised for a Year-End Rally (zacks.com)
(12/20) Amazon: $3 Trillion Is A Matter Of Time (seekingalpha.com)
(12/20) Amazon.com, Inc. (AMZN): Among Tiger Global Management’s Long-Term Stock Picks(insidermonkey.com)
(12/20) Worker Strike Hits Amazon at Peak Holiday Season (247wallst.com)
(12/20) AWS CEO Matt Garman on startups, nuclear power, and soaring AI compute costs (fortune.com)

Alphabet Inc. (GOOGL)

(12/20) Jabil’s Winning Streak Begins: Market Bottom Set, Future in Focus (GOOGL) (marketbeat.com)
(12/20) Ad Sales to Top $1 Trillion: 3 Stocks to Take Advantage (GOOGL) (marketbeat.com)
(12/20) 3 Giant Tech Stocks That Initiated Dividends This Year (fool.com)
(12/20) Google’s End-of-Year Quantum Breakthrough: What It Means for the AI Stock in 2025 (fool.com)
(12/19) Is Alphabet Inc. (GOOGL) the Best Growth Stock to Invest in Now? (insidermonkey.com)

Meta Platforms, Inc. (META)

insider Jennifer Newstead sold 905 shares of the firm’s stock in a transaction dated Tuesday, December 17th. The stock was sold at an average price of $626.66, for a total transaction of $567,127.30. Following the completion of the transaction, the insider now owns 34,725 shares of the company’s stock, valued at $21,760,768.50. This trade represents a 2.54 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through the SEC website.
(12/20) Hollywood Is Getting Left Behind in Recovering Film and TV Industry (financialpost.com)
(12/20) Meta Platforms, Inc. (META): Among Tiger Global Management’s Long-Term Stock Picks(insidermonkey.com)
(12/20) Insider Selling: Meta Platforms, Inc. (NASDAQ:META) Insider Sells 905 Shares of Stock (insidertrades.com)
(12/20) 3 Giant Tech Stocks That Initiated Dividends This Year (fool.com)
(12/20) 2 Technology Stocks That Could Help Make You a Fortune (fool.com)

Microsoft Co. (MSFT)

(12/20) How To Earn $500 A Month From Microsoft Stock (benzinga.com)
(12/20) Microsoft Corporation (MSFT): Among Tiger Global Management’s Long-Term Stock Picks(insidermonkey.com)
(12/20) Harworth completes £53.4m land sale to Microsoft (investing.com)
(12/20) Microsoft Dominates Nvidia Chip Market, Surpassing U.S. and Chinese Rivals (gurufocus.com)
(12/20) Tesla Stock vs. Microsoft Stock: Billionaire Philippe Laffont Is Buying One and Selling the Other (fool.com)

MANAGE YOUR WATCHLIST

Analysts’ Upgrades

Affirm (NASDAQ:AFRM) was upgraded by analysts at JMP Securities from a “market perform” rating to an “outperform” rating. They now have a $78.00 price target on the stock. This represents a 22.2% upside from the current price of $63.83.

Ares Management (NYSE:ARES) was upgraded by analysts at Keefe, Bruyette & Woods from a “market perform” rating to an “outperform” rating. They now have a $202.00 price target on the stock, up previously from $166.00. This represents a 16.5% upside from the current price of $173.41.

Atmos Energy (NYSE:ATO) was upgraded by analysts at Argus from a “hold” rating to a “buy” rating. They now have a $150.00 price target on the stock. This represents a 8.4% upside from the current price of $138.39.

BlackBerry (NYSE:BB) was upgraded by analysts at TD Securities from a “hold” rating to a “buy” rating. They now have a $4.00 price target on the stock. This represents a 14.9% upside from the current price of $3.48.

Brookline Bancorp (NASDAQ:BRKL) was upgraded by analysts at Raymond James from a “market perform” rating to a “strong-buy” rating. They now have a $16.00 price target on the stock. This represents a 35.8% upside from the current price of $11.78.

Camden National (NASDAQ:CAC) was upgraded by analysts at Raymond James from a “market perform” rating to an “outperform” rating. They now have a $50.00 price target on the stock. This represents a 15.4% upside from the current price of $43.34.

DoorDash (NASDAQ:DASH) was upgraded by analysts at Argus from a “hold” rating to a “buy” rating.The current price is $165.76.

Brinker International (NYSE:EAT) was upgraded by analysts at Morgan Stanley from an “underweight” rating to an “equal weight” rating. They now have a $115.00 price target on the stock, up previously from $70.00. This represents a 12.3% downside from the current price of $131.08.

Evercore (NYSE:EVR) was upgraded by analysts at Keefe, Bruyette & Woods from a “market perform” rating to an “outperform” rating. They now have a $339.00 price target on the stock, up previously from $269.00. This represents a 24.7% upside from the current price of $271.93.

FedEx (NYSE:FDX) was upgraded by analysts at Loop Capital from a “hold” rating to a “buy” rating. They now have a $365.00 price target on the stock, up previously from $288.00. This represents a 31.6% upside from the current price of $277.45.

FREYR Battery (NYSE:FREY) was upgraded by analysts at BTIG Research from a “neutral” rating to a “buy” rating. They now have a $4.00 price target on the stock. This represents a 85.2% upside from the current price of $2.16.

Federal Realty Investment Trust (NYSE:FRT) was upgraded by analysts at JPMorgan Chase & Co. from a “neutral” rating to an “overweight” rating. They now have a $125.00 price target on the stock, up previously from $122.00. This represents a 13.2% upside from the current price of $110.46.

Innoviz Technologies (NASDAQ:INVZ) was upgraded by analysts at Rosenblatt Securities from a “neutral” rating to a “buy” rating. They now have a $4.00 price target on the stock, up previously from $3.25. This represents a 251.2% upside from the current price of $1.14.

Johnson Controls International (NYSE:JCI) was upgraded by analysts at Argus from a “hold” rating to a “buy” rating. They now have a $88.00 price target on the stock. This represents a 11.1% upside from the current price of $79.24.

Kilroy Realty (NYSE:KRC) was upgraded by analysts at JPMorgan Chase & Co. from a “neutral” rating to an “overweight” rating. They now have a $49.00 price target on the stock, up previously from $45.00. This represents a 21.1% upside from the current price of $40.45.

Moelis & Company (NYSE:MC) was upgraded by analysts at Keefe, Bruyette & Woods from a “market perform” rating to an “outperform” rating. They now have a $86.00 price target on the stock, up previously from $71.00. This represents a 18.9% upside from the current price of $72.30.

Spire (NYSE:SR) was upgraded by analysts at Mizuho from a “neutral” rating to an “outperform” rating. They now have a $76.00 price target on the stock, up previously from $65.00. This represents a 13.7% upside from the current price of $66.84.

State Street (NYSE:STT) was upgraded by analysts at JPMorgan Chase & Co. from an “underweight” rating to a “neutral” rating. They now have a $95.00 price target on the stock. This represents a 1.3% downside from the current price of $96.22.

Tradeweb Markets (NASDAQ:TW) was upgraded by analysts at Keefe, Bruyette & Woods from a “market perform” rating to an “outperform” rating. They now have a $150.00 price target on the stock, up previously from $143.00. This represents a 14.3% upside from the current price of $131.20.

Willis Towers Watson Public (NASDAQ:WTW) was upgraded by analysts at Jefferies Financial Group Inc. from a “hold” rating to a “buy” rating. They now have a $382.00 price target on the stock, up previously from $352.00. This represents a 21.7% upside from the current price of $313.93.

VIEW MORE UPGRADES

This Is Your Chance To Have That “I knew it before anyone else” Moment (ad)

How do you spot the next big winner before everyone else?

Trade Stocks has the answer, and it comes in the form of our exciting new sponsor: InsiderOwl.

CLICK HERE TO JOIN TRADE STOCKS AND RECEIVE YOUR FIRST INSIDER OWL REPORT

Analysts’ Downgrades

Biogen (NASDAQ:BIIB) was downgraded by analysts at BMO Capital Markets from an “outperform” rating to a “market perform” rating. They now have a $164.00 price target on the stock, down previously from $230.00. This represents a 11.4% upside from the current price of $147.22.

Cabaletta Bio (NASDAQ:CABA) was downgraded by analysts at Evercore ISI from an “outperform” rating to an “inline” rating. They now have a $6.00 price target on the stock, down previously from $15.00. This represents a 152.1% upside from the current price of $2.38.

Exelixis (NASDAQ:EXEL) was downgraded by analysts at BMO Capital Markets from an “outperform” rating to a “market perform” rating. They now have a $40.00 price target on the stock, up previously from $36.00. This represents a 20.2% upside from the current price of $33.27.

Halliburton (NYSE:HAL) was downgraded by analysts at Griffin Securities from a “buy” rating to a “neutral” rating.The current price is $26.06.

Hookipa Pharma (NASDAQ:HOOK) was downgraded by analysts at Royal Bank of Canada from an “outperform” rating to a “sector perform” rating. They now have a $2.00 price target on the stock, down previously from $48.00. This represents a 4.8% downside from the current price of $2.10.

Healthcare Realty Trust (NYSE:HR) was downgraded by analysts at JPMorgan Chase & Co. from an “overweight” rating to a “neutral” rating. They now have a $19.00 price target on the stock. This represents a 12.8% upside from the current price of $16.85.

Innovative Industrial Properties (NYSE:IIPR) was downgraded by analysts at Compass Point from a “buy” rating to a “neutral” rating. They now have a $78.00 price target on the stock, down previously from $125.00. This represents a 4.6% upside from the current price of $74.55.

Kimco Realty (NYSE:KIM) was downgraded by analysts at JPMorgan Chase & Co. from an “overweight” rating to a “neutral” rating. They now have a $26.00 price target on the stock. This represents a 12.3% upside from the current price of $23.16.

Lazard (NYSE:LAZ) was downgraded by analysts at Keefe, Bruyette & Woods from an “outperform” rating to a “market perform” rating. They now have a $57.00 price target on the stock, down previously from $65.00. This represents a 12.3% upside from the current price of $50.77.

Lennar (NYSE:LEN) was downgraded by analysts at BTIG Research from a “buy” rating to a “neutral” rating.The current price is $137.08.

Lineage (NASDAQ:LINE) was downgraded by analysts at JPMorgan Chase & Co. from an “overweight” rating to a “neutral” rating. They now have a $75.00 price target on the stock, down previously from $78.00. This represents a 31.0% upside from the current price of $57.25.

Lamb Weston (NYSE:LW) was downgraded by analysts at Citigroup Inc. from a “buy” rating to a “neutral” rating. They now have a $68.00 price target on the stock, down previously from $90.00. This represents a 9.6% upside from the current price of $62.03.

Merck & Co., Inc. (NYSE:MRK) was downgraded by analysts at BMO Capital Markets from an “outperform” rating to a “market perform” rating. They now have a $105.00 price target on the stock, down previously from $136.00. This represents a 6.1% upside from the current price of $98.95.

NIKE (NYSE:NKE) was downgraded by analysts at Telsey Advisory Group from an “outperform” rating to a “market perform” rating. They now have a $80.00 price target on the stock, down previously from $93.00. This represents a 5.4% upside from the current price of $75.88.

Oracle (NYSE:ORCL) was downgraded by analysts at Monness Crespi & Hardt from a “neutral” rating to a “sell” rating. They now have a $130.00 price target on the stock. This represents a 22.0% downside from the current price of $166.67.

PBF Energy (NYSE:PBF) was downgraded by analysts at TD Cowen from a “hold” rating to a “sell” rating. They now have a $20.00 price target on the stock, down previously from $27.00. This represents a 20.7% downside from the current price of $25.23.

RxSight (NASDAQ:RXST) was downgraded by analysts at Stifel Nicolaus from a “buy” rating to a “hold” rating. They now have a $40.00 price target on the stock, down previously from $65.00. This represents a 15.2% upside from the current price of $34.71.

Schlumberger (NYSE:SLB) was downgraded by analysts at Griffin Securities from a “buy” rating to a “neutral” rating.The current price is $37.11.

Spero Therapeutics (NASDAQ:SPRO) was downgraded by analysts at Evercore ISI from an “outperform” rating to an “in-line” rating. They now have a $5.00 price target on the stock. This represents a 420.8% upside from the current price of $0.96.

VIEW MORE DOWNGRADES

Blackrock’s Sending THIS Crypto Higher on Purpose (ad)

It’s a groundbreaking opportunity that could be poised for extraordinary gains.

The catalyst behind this surge is a massive new blockchain development…

YES, I WANT THE #1 CRYPTO NOW

Analysts’ New Coverage

Montana Technologies (NASDAQ:AIRJ) is now covered by analysts at HC Wainwright. They set a “buy” rating and a $12.00 price target on the stock. This represents a 33.5% upside from the current price of $8.99.

Applied Digital (NASDAQ:APLD) is now covered by analysts at Cantor Fitzgerald. They set an “overweight” rating and a $15.00 price target on the stock. This represents a 86.3% upside from the current price of $8.05.

Arrow Financial (NASDAQ:AROW) is now covered by analysts at Piper Sandler. They set a “neutral” rating and a $32.00 price target on the stock. This represents a 12.8% upside from the current price of $28.37.

Atara Biotherapeutics (NASDAQ:ATRA) is now covered by analysts at Rodman & Renshaw. They set a “buy” rating and a $25.00 price target on the stock. This represents a 146.3% upside from the current price of $10.15.

Chemung Financial (NASDAQ:CHMG) is now covered by analysts at Piper Sandler. They set a “neutral” rating and a $57.00 price target on the stock. This represents a 12.7% upside from the current price of $50.58.

California Resources (NYSE:CRC) is now covered by analysts at JPMorgan Chase & Co.. They set a “neutral” rating and a $63.00 price target on the stock. This represents a 24.2% upside from the current price of $50.72.

Definitive Healthcare (NASDAQ:DH) is now covered by analysts at Stephens. They set an “equal weight” rating and a $5.00 price target on the stock. This represents a 19.0% upside from the current price of $4.20.

Dianthus Therapeutics (NASDAQ:DNTH) is now covered by analysts at TD Cowen. They set a “buy” rating on the stock.The current price is $22.95.

Doximity (NASDAQ:DOCS) is now covered by analysts at Stephens. They set an “equal weight” rating and a $55.00 price target on the stock. This represents a 0.8% upside from the current price of $54.54.

Fair Isaac (NYSE:FICO) is now covered by analysts at JPMorgan Chase & Co.. They set a “neutral” rating and a $2,150.00 price target on the stock. This represents a 5.8% upside from the current price of $2,032.47.

Financial Institutions (NASDAQ:FISI) is now covered by analysts at Piper Sandler. They set an “overweight” rating and a $33.00 price target on the stock. This represents a 22.3% upside from the current price of $26.98.

IQVIA (NYSE:IQV) is now covered by analysts at Stephens. They set an “overweight” rating and a $250.00 price target on the stock. This represents a 27.7% upside from the current price of $195.81.

Iris Energy (NASDAQ:IREN) is now covered by analysts at BTIG Research. They set a “buy” rating and a $33.00 price target on the stock. This represents a 192.0% upside from the current price of $11.30.

LCNB (NASDAQ:LCNB) is now covered by analysts at Hovde Group. They set a “market perform” rating and a $16.25 price target on the stock. This represents a 2.5% upside from the current price of $15.86.

Liquidia (NASDAQ:LQDA) is now covered by analysts at Wells Fargo & Company. They set an “overweight” rating and a $20.00 price target on the stock. This represents a 84.3% upside from the current price of $10.85.

Moody’s (NYSE:MCO) is now covered by analysts at Citigroup Inc.. They set a “buy” rating and a $565.00 price target on the stock. This represents a 21.9% upside from the current price of $463.57.

MannKind (NASDAQ:MNKD) is now covered by analysts at Wells Fargo & Company. They set an “overweight” rating and a $9.00 price target on the stock. This represents a 34.5% upside from the current price of $6.69.

Mind Medicine (MindMed) (NASDAQ:MNMD) is now covered by analysts at Chardan Capital. They set a “buy” rating and a $20.00 price target on the stock. This represents a 184.5% upside from the current price of $7.03.

Motorcar Parts of America (NASDAQ:MPAA) is now covered by analysts at Cantor Fitzgerald. They set an “overweight” rating and a $14.00 price target on the stock. This represents a 75.9% upside from the current price of $7.96.

Northrim BanCorp (NASDAQ:NRIM) is now covered by analysts at Hovde Group. They set an “outperform” rating and a $96.50 price target on the stock. This represents a 25.0% upside from the current price of $77.21.

OptimizeRx (NASDAQ:OPRX) is now covered by analysts at Stephens. They set an “equal weight” rating and a $5.50 price target on the stock. This represents a 12.2% upside from the current price of $4.90.

Paysign (NASDAQ:PAYS) is now covered by analysts at Lake Street Capital. They set a “buy” rating and a $6.00 price target on the stock. This represents a 103.4% upside from the current price of $2.95.

Vaxcyte (NASDAQ:PCVX) is now covered by analysts at The Goldman Sachs Group, Inc.. They set a “buy” rating and a $135.00 price target on the stock. This represents a 55.2% upside from the current price of $86.96.

PennantPark Floating Rate Capital (NASDAQ:PFLT) is now covered by analysts at Raymond James. They set a “market perform” rating on the stock.The current price is $10.71.

Pagaya Technologies (NASDAQ:PGY) is now covered by analysts at UBS Group AG. They set a “neutral” rating and a $11.00 price target on the stock. This represents a 24.4% upside from the current price of $8.84.

Prothena (NASDAQ:PRTA) is now covered by analysts at Chardan Capital. They set a “buy” rating and a $40.00 price target on the stock. This represents a 158.1% upside from the current price of $15.50.

Reddit (NYSE:RDDT) is now covered by analysts at Guggenheim. They set a “buy” rating and a $210.00 price target on the stock. This represents a 29.0% upside from the current price of $162.77.

Rigetti Computing (NASDAQ:RGTI) is now covered by analysts at Craig Hallum. They set a “buy” rating and a $12.00 price target on the stock. This represents a 43.0% upside from the current price of $8.39.

Avidity Biosciences (NASDAQ:RNA) is now covered by analysts at HC Wainwright. They set a “buy” rating and a $72.00 price target on the stock. This represents a 129.5% upside from the current price of $31.37.

Rhythm Pharmaceuticals (NASDAQ:RYTM) is now covered by analysts at Oppenheimer Holdings Inc.. They set an “outperform” rating and a $76.00 price target on the stock. This represents a 32.2% upside from the current price of $57.50.

S&P Global (NYSE:SPGI) is now covered by analysts at Citigroup Inc.. They set a “buy” rating and a $600.00 price target on the stock. This represents a 23.3% upside from the current price of $486.67.

Stoke Therapeutics (NASDAQ:STOK) is now covered by analysts at Chardan Capital. They set a “buy” rating and a $24.00 price target on the stock. This represents a 113.1% upside from the current price of $11.26.

Savara (NASDAQ:SVRA) is now covered by analysts at Wells Fargo & Company. They set an “overweight” rating and a $8.00 price target on the stock. This represents a 148.4% upside from the current price of $3.22.

Tompkins Financial (NYSEAMERICAN:TMP) is now covered by analysts at Piper Sandler. They set a “neutral” rating and a $70.00 price target on the stock. This represents a 1.6% upside from the current price of $68.91.

Veeva Systems (NYSE:VEEV) is now covered by analysts at Stephens. They set an “overweight” rating and a $280.00 price target on the stock. This represents a 26.5% upside from the current price of $221.28.

Vital Farms (NASDAQ:VITL) is now covered by analysts at Craig Hallum. They set a “buy” rating and a $50.00 price target on the stock. This represents a 25.1% upside from the current price of $39.96.

Valvoline (NYSE:VVV) is now covered by analysts at Stifel Nicolaus. They set a “hold” rating and a $42.00 price target on the stock. This represents a 14.7% upside from the current price of $36.63.

VIEW MORE NEW COVERAGE

Calendars from MarketBeat

U.S. Analyst Ratings

Corporate Buybacks

Cryptocurrencies

Dividend Declarations

Earnings Announcements

Earnings Conference Calls

Economic Reports

Gap Up/Down Stocks

Insider Trades

Initial Public Offerings (IPOs)

Most Active Stocks

Percentage Gainers/Decliners

Sector Performance

Short Interest

Stock Splits

Unusual Options Volume

Unusual Trading Volume

GET 30 DAYS OF MARKETBEAT ALL ACCESS FREE

Best-in-Class Portfolio Monitoring

View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations

Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat’s trending stocks report.
Advanced Stock Screeners and Research Tools

Identify stocks that meet your criteria using seven unique stock screeners. See what’s happening in the market right now with MarketBeat’s real-time news feed. Export data to Excel for your own analysis.

START YOUR 30-DAY FREE TRIAL

Upgrade Your Subscription

Upgrade to MarketBeat All Access and receive your premium edition of MarketBeat Daily at 9:00 AM ET.

UPGRADE NOW

Manage Your Watchlist

View and add up to five holdings to your watchlist.

VIEW MY PORTFOLIO

Join Our Facebook Group

Join MarketBeat’s free stock discussion and trading idea group on Facebook.

JOIN NOW

Gift Cards Make Great Last-Minute Gifts 🎁

The RJ Hamster morning Show for 21 December

RJ Hamster

🌎 Ares Management Upgraded, Vaxcyte Initiated, Rhythm Pharmaceuticals Initiated and more…

🌎 Ares Management Upgraded, Vaxcyte Initiated, Rhythm Pharmaceuticals Initiated…

DECEMBER 20TH, 2024

Why Trump’s Win Can’t Stop the Coming Crisis – Protect Yourself Now (ad)

Today’s Top Stories

2 Underrated Quantum Computing Companies Starting to Rally

Missed Nvidia? Buy Elon Musk’s “Silent Partner” (Ad)

Trump was poised to inherit a strong economy. Then things got rocky and he added to the uncertainty

Why Wall Street Sees Major Upside for PayPal Stock

BITCOIN (Ad)

Russian central bank holds rates steady even as war against Ukraine fuels inflation

Cintas Shares Slide: A Prime Opportunity to Buy the Dip

Quick Links

25X predicted for “Amazon Coin” – starting December 16th? (ad)

Your Watchlist

MANAGE YOUR WATCHLIST AND MONITOR YOUR PORTFOLIO

Analysts’ Upgrades

This Is Your Chance To Have That “I knew it before anyone else” Moment (ad)

Analysts’ Downgrades

Blackrock’s Sending THIS Crypto Higher on Purpose (ad)

Analysts’ New Coverage

Calendars from MarketBeat

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

Like this:

🌎 Ares Management Upgraded, Vaxcyte Initiated, Rhythm Pharmaceuticals Initiated and more…

DECEMBER 20TH, 2024

Why Trump’s Win Can’t Stop the Coming Crisis – Protect Yourself Now (ad)

Today’s Top Stories

Quick Links

25X predicted for “Amazon Coin” – starting December 16th? (ad)

Your Watchlist

Analysts’ Upgrades

This Is Your Chance To Have That “I knew it before anyone else” Moment (ad)

Analysts’ Downgrades

Blackrock’s Sending THIS Crypto Higher on Purpose (ad)

Analysts’ New Coverage

Calendars from MarketBeat

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

Share this:

Like this:

Related articles